MoneyWorks4Me

Cipla registers 36% growth in Q4 net

11 May 2012 Evaluate

Drug major Cipla has reported a growth of 36.32% in its net profit to Rs 291.74 crore for the fourth quarter ended March 31, 2012. The company had posted a net profit of Rs 214 crore for the quarter ended March 31, 2011.

The company’s total income stood at Rs 1,865.57 crore for the quarter ended March 31, 2012 as against Rs 1,667.74 crore for the corresponding period previous fiscal, up by 11.86%.

The company’s net profit for the year ended March 31, 2012, rose 17.03% to Rs 1,123.96 crore from Rs 960.39 crore for the year ago period. Total income of the company surged by10.21% to Rs 6,977.50 crore for the year ended March this year from Rs 6,331.09 crore for corresponding period last year.

Peers
Company Name CMP
Sun Pharma. Inds. 1852.40
Dr. Reddys Labs. 1223.45
Cipla 1391.45
Lupin 2070.00
Zydus Lifesciences 1213.00
View more..